Indromig-600 Bioequivalent Antibiotic for Switch Over Therapy
Linezolid therapy has been found to cure or improve more than 90 percent of patients treated for skin and soft tissue infections. Dosages twice daily produced clinical success rates exceeding 89 percent in patients with complicated and uncomplicated skin/soft tissue infections. Linezolid also exhibited similar efficacy to oxacillin / dicloxacillin and vancomycin- Drugs. 2000; 59:815–27.
Linezolid 600mg